羚锐制药,600285,收入构成,报告日期,2022-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 贴膏剂,93639,22280,71359,76.21%,65.39% 软膏剂,9160,2084,7076,77.25%,6.48% 其他(补充),125,55,70,55.8%,0.06% 其他,6125,3236,2889,47.17%,2.65% 片剂,9694,4055,5639,58.17%,5.17% 胶囊剂,31525,9432,22093,70.08%,20.25% 羚锐制药,600285,收入构成,报告日期,2021-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 贴膏剂,162419,40113,122306,75.3%,61.14% 软膏剂,12086,2442,9644,79.79%,4.82% 其他(补充),348,75,273,78.4%,0.14% 其他,13070,7134,5936,45.42%,2.97% 片剂,14795,5501,9294,62.82%,4.65% 胶囊剂,66633,14034,52599,78.94%,26.29% 羚锐制药,600285,收入构成,报告日期,2021-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 贴膏剂,84125,19339,64786,77.01%,63.6% 软膏剂,6837,1194,5643,82.54%,5.54% 其他(补充),219,42,177,80.83%,0.17% 其他,6255,2852,3403,54.4%,3.34% 片剂,6784,2573,4211,62.07%,4.13% 胶囊剂,31328,7680,23648,75.49%,23.21% 羚锐制药,600285,收入构成,报告日期,2020-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 贴膏剂,141678,31921,109757,77.47%,61.21% 软膏剂,13480,2222,11258,83.52%,6.28% 其他(补充),344,126,218,63.48%,0.12% 其他,9333,4375,4958,53.12%,2.76% 片剂,10832,4299,6532,60.31%,3.64% 胶囊剂,57491,10898,46593,81.04%,25.98% 羚锐制药,600285,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 贴膏剂,71307,15307,56000,78.53%,61.26% 软膏剂,5573,869,4704,84.41%,5.15% 其他(补充),155,27,128,82.84%,0.14% 其他,4574,2247,2327,50.87%,2.55% 片剂,4863,2019,2844,58.48%,3.11% 胶囊剂,30983,5572,25411,82.02%,27.8% 羚锐制药,600285,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,7910,3593,4317,54.58%,2.59% 片剂,8641,4309,4332,50.13%,2.6% 其他(补充),335,41,294,87.74%,0.18% 胶囊剂,52474,9039,43435,82.77%,26.05% 软膏剂,8116,1006,7110,87.6%,4.26% 贴膏剂,138229,31005,107224,77.57%,64.32% 羚锐制药,600285,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),215,26,190,88.09%,0.21% 胶囊剂,29306,5354,23952,81.73%,26.6% 软膏剂,4742,677,4065,85.72%,4.51% 贴膏剂,74218,17159,57059,76.88%,63.37% 其他,3882,1752,2130,54.87%,2.37% 片剂,4506,1866,2640,58.59%,2.93% 羚锐制药,600285,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 软膏剂,9724,1612,8112,83.43%,5.19% 贴膏剂,125608,30343,95265,75.84%,61% 片剂,8715,4292,4423,50.75%,2.83% 胶囊剂,52800,9326,43474,82.34%,27.84% 其他(补充),213,14,199,93.22%,0.13% 其他,8251,3546,4705,57.03%,3.01% 羚锐制药,600285,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 胶囊剂,26574,4678,21896,82.4%,26.33% 其他,4421,1755,2666,60.3%,3.21% 片剂,4496,1912,2584,57.47%,3.11% 贴膏剂,69834,18083,51751,74.11%,62.24% 软膏剂,4908,772,4136,84.27%,4.97% 其他(补充),151,30,120,79.9%,0.14% 羚锐制药,600285,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),256,17,239,93.29%,0.18% 贴膏剂,121507,30972,90535,74.51%,66.98% 胶囊,42507,11648,30859,72.6%,22.83% 其他,6696,2612,4084,60.99%,3.02% 软膏剂,6010,1239,4771,79.38%,3.53% 片剂,7876,3191,4685,59.48%,3.47% 羚锐制药,600285,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 分部间抵销,-1343,-1361,18,-1.36%,0.13% 其他,2431,2689,-257,-10.58%,-1.86% 医药分部,82180,68118,14062,17.11%,101.73% 羚锐制药,600285,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),219,48,171,77.95%,0.18% 其他,4940,2427,2513,50.87%,2.59% 软膏剂,4134,1220,2914,70.48%,3% 胶囊,22583,11381,11202,49.6%,11.54% 片剂,10842,4970,5872,54.16%,6.05% 贴膏剂,101213,26833,74380,73.49%,76.64% 羚锐制药,600285,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),95,-- ,-- ,--,0% 其他,1722,1068,654,37.98%,1.47% 软膏剂,2514,824,1690,67.22%,3.8% 胶囊,9616,4812,4804,49.96%,10.79% 片剂,4070,1961,2109,51.82%,4.74% 贴膏剂,48341,13089,35252,72.92%,79.2% 羚锐制药,600285,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),162,1,162,99.66%,0.24% 其他,2546,1714,832,32.7%,1.23% 软膏剂,4031,1341,2690,66.73%,3.99% 胶囊剂,17659,8864,8795,49.8%,13.03% 片剂,8800,4298,4502,51.15%,6.67% 贴膏剂,73879,23383,50496,68.35%,74.84% 羚锐制药,600285,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,772,659,113,14.64%,0.35% 片剂,3915,1997,1918,48.99%,5.97% 其他(补充),112,-- ,-- ,--,0% 胶囊,7975,4017,3958,49.63%,12.32% 软膏剂,1924,648,1276,66.32%,3.97% 贴膏剂,37493,12639,24854,66.29%,77.38% 羚锐制药,600285,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),424,283,140,33.1%,0.28% 胶囊,16587,8503,8084,48.74%,16.36% 片剂,7283,3562,3721,51.09%,7.53% 其他,1672,1429,243,14.53%,0.49% 软膏剂,2930,991,1939,66.18%,3.92% 贴膏剂,53732,18449,35283,65.66%,71.41% 羚锐制药,600285,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 软膏剂类,1372,480,892,65.02%,3.58% 片剂类,3106,1458,1649,53.07%,6.61% 其他(补充),85,10,75,88.02%,0.3% 胶囊类,7491,3858,3633,48.5%,14.58% 橡胶膏剂类,28537,9944,18593,65.15%,74.61% 其他,767,687,79,10.35%,0.32% 羚锐制药,600285,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),89,18,71,79.96%,0.18% 其他,1849,1554,295,15.96%,0.74% 胶囊类,14125,7212,6913,48.94%,17.37% 片剂类,6420,2901,3520,54.82%,8.85% 膏剂类,46214,17223,28991,62.73%,72.86% 羚锐制药,600285,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),65,4,61,94.14%,0.3% 其他,1592,896,696,43.73%,3.48% 胶囊,6722,3476,3246,48.29%,16.22% 片剂,2840,1289,1552,54.63%,7.75% 橡胶膏剂,23126,8672,14454,62.5%,72.24% 羚锐制药,600285,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),133,34,100,74.74%,0.32% 其他,2048,1385,663,32.35%,2.13% 胶囊类,11969,6388,5581,46.63%,17.96% 片剂类,4729,2138,2591,54.78%,8.34% 膏剂类,37391,15255,22136,59.2%,71.24% 羚锐制药,600285,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他业务,179,3,175,98.16%,1.1% 其他(主营),1735,1081,654,37.68%,4.09% 产品加工,-- ,-- ,-- ,--,0% 销售材料,-- ,-- ,-- ,--,0% 片剂,2253,1021,1233,54.71%,7.71% 橡胶膏剂,18943,7744,11199,59.12%,70.06% 胶囊,5797,3073,2724,46.98%,17.04% 羚锐制药,600285,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他业务,126,48,79,62.1%,0.33% 其他(主营),3037,1797,1240,40.84%,5.16% 销售材料,19,18,1,7.84%,0.01% 胶囊类,8622,4790,3832,44.45%,15.94% 片剂类,3557,1688,1869,52.54%,7.77% 橡胶膏剂类,29516,12501,17015,57.65%,70.79% 羚锐制药,600285,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(主营),1544,977,567,36.74%,4.4% 其他(补充),78,0,77,99.64%,0.6% 产品加工,1,-- ,-- ,--,0% 销售材料,0,0,0,9.78%,0% 胶囊类,3667,2075,1592,43.4%,12.36% 片剂类,1540,748,791,51.4%,6.14% 橡胶膏剂类,16520,6668,9852,59.64%,76.49% 羚锐制药,600285,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,3335,2042,1293,38.78%,6.03% 胶囊类,4403,2536,1867,42.41%,8.71% 片剂类,1964,939,1024,52.16%,4.78% 橡胶膏剂类,28395,11138,17257,60.78%,80.48% 羚锐制药,600285,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1742,1032,710,40.76%,6.99% 胶囊类,2047,1157,890,43.5%,8.76% 片剂类,840,345,495,58.95%,4.87% 橡胶膏剂类,13016,4947,8069,61.99%,79.38% 羚锐制药,600285,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 产品加工,1,3,-1,-81.23%,-0% 销售材料,13,5,8,60.08%,0.03% 其他,23,-- ,-- ,--,0% 胶囊类,3102,1901,1201,38.71%,4.51% 片剂类,1379,824,555,40.23%,2.08% 橡胶膏剂类,35954,11081,24873,69.18%,93.38% 羚锐制药,600285,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2800,2022,778,27.79%,5.38% 胶囊类,1378,793,586,42.48%,4.05% 片剂类,650,391,259,39.81%,1.79% 橡胶膏剂类,18593,5764,12829,69%,88.77% 羚锐制药,600285,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 处理废品,10,3,8,74.61%,0.03% 产品加工,26,21,5,19.37%,0.02% 销售材料,14,20,-7,-49.52%,-0.03% 其他,5051,3463,1589,31.45%,6.69% 胶囊类,2000,1359,641,32.06%,2.7% 片剂类,1034,768,266,25.7%,1.12% 橡胶膏剂类,34190,12929,21261,62.18%,89.47% 羚锐制药,600285,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 硬膏剂类,15593,5760,9833,63.06%,90.1% 其他,2455,1717,738,30.07%,6.77% 胶囊类,824,609,214,26.04%,1.97% 片剂类,480,355,125,26.09%,1.15% 处理废品,5,0,5,100%,0.05% 产品加工,20,14,6,29.7%,0.05% 销售材料,7,16,-9,-123.27%,-0.08% 羚锐制药,600285,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,3346,2379,967,28.9%,3.75% 针剂类,11972,8332,3640,30.4%,14.11% 胶囊类,1908,1462,446,23.35%,1.73% 片剂类,675,504,171,25.29%,0.66% 硬膏剂类,34079,13506,20573,60.37%,79.75% 羚锐制药,600285,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 合并抵消,-35,-35,0,0%,0% 其他,1329,920,408,30.72%,3.75% 针剂类,4740,3625,1115,23.52%,10.23% 胶囊类,842,626,215,25.56%,1.97% 片剂类,330,267,63,19.15%,0.58% 硬膏剂类,15910,6814,9096,57.17%,83.47% 羚锐制药,600285,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,3097,2282,815,26.32%,4.44% 针剂,5743,4527,1216,21.17%,6.63% 胶囊,1657,1258,399,24.09%,2.18% 片剂,575,434,141,24.57%,0.77% 硬膏剂,28145,12364,15781,56.07%,85.99% 羚锐制药,600285,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 硬膏剂,6455,3069,3386,52.45%,100% 羚锐制药,600285,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1654,1282,372,22.49%,4.58% 针剂,2209,1683,526,23.82%,6.48% 胶囊,640,440,199,31.17%,2.46% 片剂,228,169,60,26.22%,0.74% 膏剂,12781,5820,6960,54.46%,85.74% 羚锐制药,600285,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 硬膏剂,3752,1954,1797,47.91%,100% 羚锐制药,600285,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,4165,3236,929,22.31%,4.84% 针剂,5702,4651,1051,18.43%,5.48% 胶囊,1751,1052,699,39.93%,3.64% 片剂,817,533,284,34.71%,1.48% 硬膏剂,27502,11270,16232,59.02%,84.56% 羚锐制药,600285,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 针剂,2036,1702,334,16.4%,7.74% 硬膏剂,7041,3062,3979,56.52%,92.26% 羚锐制药,600285,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2162,1712,450,20.83%,4.6% 胶囊,833,462,371,44.56%,3.79% 片剂,407,226,180,44.35%,1.84% 针剂,2695,2129,566,21%,5.78% 硬膏剂,13209,4983,8227,62.28%,83.99% 羚锐制药,600285,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,1776,1266,510,28.72%,14.91% 针剂,1400,1152,248,17.71%,7.25% 硬膏剂,4475,1812,2663,59.52%,77.84% 羚锐制药,600285,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 内部抵消,-87,0,-87,100%,-0.42% 其他,4471,0,4471,100%,21.45% 针剂,5721,4853,868,15.17%,4.16% 硬膏剂,23900,8312,15587,65.22%,74.8% 羚锐制药,600285,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 硬膏剂,3012,1189,1823,60.52%,100% 羚锐制药,600285,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 相互抵销,-32,-32,0,0%,0% 其他,617,367,249,40.44%,2.55% 针剂,2631,2420,211,8.03%,2.16% 胶囊,915,478,437,47.74%,4.47% 片剂,577,204,374,64.75%,3.82% 硬膏剂,12389,3880,8508,68.68%,87% 羚锐制药,600285,收入构成,报告日期,2004-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 硬膏剂,4756,1524,3232,67.95%,100% 羚锐制药,600285,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1095,544,551,50.31%,3.53% 片剂类,1361,359,1002,73.65%,6.42% 胶囊剂类,1986,841,1145,57.65%,7.33% 膏剂类,19193,6278,12915,67.29%,82.72% 羚锐制药,600285,收入构成,报告日期,2003-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,420,232,188,44.73%,1.88% 胶囊剂,1369,633,737,53.78%,7.37% 片剂,978,210,768,78.53%,7.68% 硬膏剂,12050,3746,8305,68.92%,83.07% 羚锐制药,600285,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,265,141,123,46.63%,1.91% 胶囊剂,767,330,437,56.95%,6.77% 片剂,633,134,499,78.81%,7.73% 硬膏剂,7673,2282,5390,70.25%,83.58% 羚锐制药,600285,收入构成,报告日期,2003-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 膏剂,3097,991,2106,68.01%,100% 羚锐制药,600285,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,301,198,103,34.1%,0.77% 片剂类,1425,340,1085,76.13%,8.16% 胶囊剂类,1647,778,868,52.74%,6.53% 膏剂类,15582,4344,11238,72.12%,84.53% 羚锐制药,600285,收入构成,报告日期,2002-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2004,1013,990,49.42%,16.64% 培元通脑胶囊,15,5,10,66.17%,0.17% 胃疼宁片,426,45,382,89.51%,6.41% 参芪降糖胶囊,217,54,163,75.12%,2.74% 主要橡胶膏剂,5762,1356,4406,76.46%,74.03% 羚锐制药,600285,收入构成,报告日期,2001-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,4357,2487,1870,42.91%,15.17% 胃疼宁片,1148,127,1021,88.97%,8.28% 参芪降糖胶囊,461,166,295,63.96%,2.39% 壮骨麝香止痛膏,1532,1094,438,28.58%,3.55% 通络祛痛膏,2644,287,2358,89.16%,19.12% 骨质增生一贴灵,7074,728,6346,89.71%,51.48% 羚锐制药,600285,收入构成,报告日期,2001-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1728,0,1728,100%,23.44% 胃疼宁片,541,0,541,100%,7.33% 参芪降糖胶囊,211,0,211,100%,2.87% 壮骨麝香止痛膏,925,0,925,100%,12.54% 通络祛痛膏,503,0,503,100%,6.82% 骨质增生一贴灵,3466,0,3466,100%,47.01%